J
José M. Rayón
Publications - 17
Citations - 2888
José M. Rayón is an academic researcher. The author has contributed to research in topics: Liver transplantation & Cirrhosis. The author has an hindex of 13, co-authored 17 publications receiving 2848 citations.
Papers
More filters
Journal ArticleDOI
Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.
Marina Berenguer,Martín Prieto,Fernando San Juan,José M. Rayón,Fernando Martinez,Domingo Carrasco,Ángel Moya,Francisco Orbis,José Mir,Joaquín Berenguer +9 more
TL;DR: In this paper, the authors describe the natural history of HCV-infected recipients, particularly to determine whether survival has decreased in recent years, and compare this outcome with that observed in non-HCVinfected cirrhosis controls.
Journal ArticleDOI
Natural History of Clinically Compensated Hepatitis C Virus–Related Graft Cirrhosis After Liver Transplantation
Marina Berenguer,Martín Prieto,José M. Rayón,J. Mora,M. Pastor,Vicente Ortiz,Domingo Carrasco,Fernando San Juan,Manuel‐de‐Juan Burgueño,José Mir,Joaquín Berenguer +10 more
TL;DR: The natural history of clinically compensated HCV‐graft cirrhosis is shortened when compared with immunocompetent patients, and if retransplantation is considered, it should be performed promptly once decompensation develops.
Journal ArticleDOI
High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes
Martín Prieto,Marina Berenguer,José M. Rayón,Juan Córdoba,Lidia Argüello,Domingo Carrasco,Antonio García-Herola,Vicente Olaso,Manuel de Juan,Gobernado M,José Mir,Joaquín Berenguer +11 more
TL;DR: HCV genotype 1b–infected liver recipients are at a high risk of developing graft cirrhosis in the first 4 to 5 years following transplantation, especially those with previous rejection episodes.
Journal ArticleDOI
Contribution of obesity to hepatitis C-related fibrosis progression.
TL;DR: Obesity, advanced age at infection, and elevated ALT levels predict rapid disease progression, suggesting that measures aimed at weight reduction may play a significant role in hepatitis C management.
Journal ArticleDOI
De novo hepatitis B after liver transplantation from hepatitis B core antibody—Positive donors in an area with high prevalence of anti-HBc positivity in the donor population
Martín Prieto,Marı́a D. Gómez,Marina Berenguer,Juan Córdoba,José M. Rayón,M. Pastor,Antonio García-Herola,D. Nicolás,Domingo Carrasco,Juan F. Orbis,José Mir,Joaquín Berenguer +11 more
TL;DR: The aims of this study are to assess the risk for de novo hepatitis B in recipients of livers from anti‐ HBc+ donors in an area of high prevalence of anti‐HBc positivity in the donor population, and to analyze the risk factors for acquisition of HBV infection from anti-HBc + donors.